Going Global to Meet Local Needs
International Strategic Partners
Karyopharm Therapeutics is Libo Pharma's international strategic alliance partner for the development of LIB-101.
Karyopharm, an Israeli-founded biopharmaceutical company headquartered in Massachusetts, USA, is listed on the Nasdaq. Its team brings extensive drug development experience, with deep expertise in hematologic malignancies such as multiple myeloma and diffuse large B-cell lymphoma. Through this cross-border partnership, Libo Pharma and Karyopharm aim to accelerate the advancement of LIB-101 across multiple indications, providing patients with better treatment options.
Karyopharm, an Israeli-founded biopharmaceutical company headquartered in Massachusetts, USA, is listed on the Nasdaq. Its team brings extensive drug development experience, with deep expertise in hematologic malignancies such as multiple myeloma and diffuse large B-cell lymphoma. Through this cross-border partnership, Libo Pharma and Karyopharm aim to accelerate the advancement of LIB-101 across multiple indications, providing patients with better treatment options.
Crown Bioscience is an important strategic partner for Libo Pharma's preclinical drug testing research.
Crown Bioscience is a multinational subsidiary of the JSR Life Sciences Group, providing preclinical drug discovery and development services. Through a long-term strategic partnership, Libo Pharma has engaged Crown Bioscience to advance translational medicine research in oncology, immuno-oncology, and immunomodulation, establishing and accelerating the quality and progress of Libo Pharma's translational research in these fields.
Crown Bioscience is a multinational subsidiary of the JSR Life Sciences Group, providing preclinical drug discovery and development services. Through a long-term strategic partnership, Libo Pharma has engaged Crown Bioscience to advance translational medicine research in oncology, immuno-oncology, and immunomodulation, establishing and accelerating the quality and progress of Libo Pharma's translational research in these fields.
Strategic Partners within the Lihpao Life Sciences Group
Driven by its commitment to the public’s quality of life and health, the Lihpao Group expanded into the biomedical industry by establishing the “Lihpao Life Sciences” business group, cultivating multiple fields including precision medicine, genetic testing, and cell therapy. (Link: About the Lihpao Group)
© Copyright | LIBO PHARMA CORP. | All rights reserved | Private Policy 2024